CDE Catalog | NINDS Common Data Elements

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Subdomain Name

CRF Name

Displaying 51 - 75 of 869

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

Operations

Selected 25 rows in this page.

The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
Select all	CDE ID	CDE Name	Definition	Classification	CRF Name	Copyrighted or trademarked	Disease Name	Subdisease Name
F0024-C02007	C02007	Study drug dose	Dose of study drug taken per administration	Supplemental	Study Drug Dosing	False	General (For all diseases)	General (For all diseases)
F0022-C02010	C02010	Study drug dosage form text	Text of dosage form used to administer study drug	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0022-C02004	C02004	Study drug dispensed date and time	Date (and time, if applicable and known) on which a participant/subject was given or applied a therapeutic agent (drug, intervention therapy) used in a clinical trial protocol	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0022-C02018	C02018	Study drug dispensed count	Count of amount of study drug dispensed to the participant/subject	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0022-C02019	C02019	Study drug actual return count	Count of amount of study drug returned	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0025-C01700	C01700	Specimen accession number	Number with which the specimen taken for the tests being reported was accessioned to the record storage facility	Supplemental	Laboratory Tests and Tracking	False	General (For all diseases)	General (For all diseases)
F0004-C20391	C20391	Sex type	The sex of the subject/participant	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0003-C18751	C18751	Sex participant or subject genotype other text	The free-text field related to 'Sex participant or subject genotype type' specifying other text. The difference between male and female, based upon the interactions between genes and between the genotype and the environment. Genotype is identified based on the individual's reproductive organs and functions assigned by chromosomal complement	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0003-C17396	C17396	Sex genotype type	The difference between male and female, based upon the interactions between genes and between the genotype and the environment. Genotype is identified based on the individual's reproductive organs and functions assigned by chromosomal complement	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0004-C20399	C20399	Serious averse event end treatment indicator	Indicate whether the study was discontinued due to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20406	C20406	Serious adverse events comment text	Provide any additional information that pertains to the adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20405	C20405	Serious adverse events anticipated indicator	Indicate whether the adverse event was anticipated	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20392	C20392	Serious adverse event treatment description text	The text that describes the interventions specific to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20393	C20393	Serious adverse event start date and time	Date (and time, if applicable and known) on which the serious adverse event was first evident	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20400	C20400	Serious adverse event resolution indicator	Indicator to ask whether an adverse event ended after treatment with the study protocol drug or agent was stopped	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20408	C20408	Serious adverse event report type	Specify which type of report is being completed for the adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20415	C20415	Serious adverse event report completed date	Date when the report on the adverse event was completed	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20397	C20397	Serious adverse event relevant history text	The text that describes relevant history including pre-existing medical conditions	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20401	C20401	Serious adverse event reappearance indicator	Indicate whether the adverse event reappeared after the treatment was restarted	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20411	C20411	Serious adverse event outcome status other text	Free-text field to specify an alternate outcome attributed to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20412	C20412	Serious adverse event outcome status	Final status of the participant/subject related to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20410	C20410	Serious adverse event not resolution indicator	Indicates whether the adverse event was not resolved	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20398	C20398	Serious adverse event medication administration text	The free-text field to describe the administration of study intervention	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20395	C20395	Serious adverse event laboratory data text	The text that describes the relevant tests or laboratory data specific to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20403	C20403	Serious adverse event investigator assessment	Indicate the principal investigator's opinion of the cause of the event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)

Displaying 51 - 75 of 869

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.